# Michael Willis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-willis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,555 |
| Field | Diabetes Treatment and Management |
| h-index | 24 |
| i10-index | 36 |
| Last Known Institution | Swedish Institute for Health Economics |
| OpenAlex ID | https://openalex.org/A5050732320 |
| ORCID iD | 0000-0002-6565-7025 |
| Works | 112 |

## Researcher papers

- [The Emergence of Crack Cocaine and the Rise in Urban Crime Rates](https://scholariq.org/papers/the-emergence-of-crack-cocaine-and-the-rise-in-urban-crime-rates/)
- [Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries](https://scholariq.org/papers/cost-effectiveness-of-treating-deep-diabetic-foot-ulcers-with-promogran-in-four/)
- [International comparison of health care systems using resource profiles.](https://scholariq.org/papers/international-comparison-of-health-care-systems-using-resource-profiles/)
- [Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge](https://scholariq.org/papers/computer-modeling-of-diabetes-and-its-transparency-a-report-on-the-eighth-mount/)
- [Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations](https://scholariq.org/papers/validation-of-the-ihe-cohort-model-of-type-2-diabetes-and-the-impact-of-choice/)
- [Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries](https://scholariq.org/papers/cost-effectiveness-of-becaplermin-in-the-treatment-of-diabetic-foot-ulcers-in/)
- [Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy](https://scholariq.org/papers/down-regulation-of-bk-channel-expression-in-the-pilocarpine-model-of-temporal/)
- [Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements](https://scholariq.org/papers/reducing-uncertainty-in-value-based-pricing-using-evidence-development/)
- [The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data](https://scholariq.org/papers/the-cost-effectiveness-of-treating-diabetic-lower-extremity-ulcers-with/)
- [Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge](https://scholariq.org/papers/evaluating-the-ability-of-economic-models-of-diabetes-to-simulate-new/)
- [Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data](https://scholariq.org/papers/development-and-internal-validation-of-a-discrete-event-simulation-model-of/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Swedish Institute for Health Economics](https://scholariq.org/institutions/swedish-institute-for-health-economics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.